International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
International Stem Cell's operating cash flow for the twelve months ending Jun 30, 2026 was $369.00K, up 235.5% year over year. For fiscal 2025 it was $8.00K, down 38.5% from the year before. The highest annual figure on record is $929.00K in fiscal 2023.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.00K | -38.5% |
| FY2024 | Dec 31, 2024 | $13.00K | -98.6% |
| FY2023 | Dec 31, 2023 | $929.00K | +179.8% |
| FY2022 | Dec 31, 2022 | $332.00K | – |
| FY2021 | Dec 31, 2021 | -$1.30M | – |
| FY2020 | Dec 31, 2020 | -$341.00K | – |
| FY2019 | Dec 31, 2019 | -$1.40M | – |
| FY2018 | Dec 31, 2018 | -$1.08M | – |
| FY2017 | Dec 31, 2017 | -$2.14M | – |
| FY2016 | Dec 31, 2016 | -$4.20M | – |
| FY2015 | Dec 31, 2015 | -$4.12M | – |
| FY2014 | Dec 31, 2014 | -$6.42M | – |
| FY2013 | Dec 31, 2013 | -$5.64M | – |
| FY2012 | Dec 31, 2012 | -$6.69M | – |
| FY2011 | Dec 31, 2011 | -$6.96M | – |
| FY2010 | Dec 31, 2010 | -$6.95M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $167.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $121.00K | -46.7% |
| Q4 FY2025 | Dec 31, 2025 | $32.00K | – |
| Q3 FY2025 | Sep 30, 2025 | $49.00K | -80.9% |
| Q2 FY2025 | Jun 30, 2025 | -$300.00K | -1404.3% |
| Q1 FY2025 | Mar 31, 2025 | $227.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$74.00K | -146.0% |
| Q3 FY2024 | Sep 30, 2024 | $257.00K | +314.5% |
| Q2 FY2024 | Jun 30, 2024 | $23.00K | -95.3% |
| Q1 FY2024 | Mar 31, 2024 | -$193.00K | -189.4% |
| Q4 FY2023 | Dec 31, 2023 | $161.00K | +103.8% |
| Q3 FY2023 | Sep 30, 2023 | $62.00K | -26.2% |
| Q2 FY2023 | Jun 30, 2023 | $490.00K | +155.2% |
| Q1 FY2023 | Mar 31, 2023 | $216.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $79.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $84.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $192.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$23.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$363.00K | – |
| Q1 FY2021 | Mar 31, 2021 | -$394.00K | -248.7% |
| Q4 FY2020 | Dec 31, 2020 | -$311.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$277.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$18.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $265.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$381.00K | -1220.6% |
| Q3 FY2019 | Sep 30, 2019 | -$27.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$648.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$341.00K | – |
| Q4 FY2018 | Dec 31, 2018 | $34.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$558.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$510.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$48.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$493.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$319.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$759.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$571.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$939.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$426.00K | – |
| Q2 FY2016 | Jun 30, 2016 | -$863.00K | – |
See a number that looks wrong?